Drugs and Devices

NWHN in Action – September/October 2016

By Sarah Christopherson | Sep 9, 2016 | Comments Off on NWHN in Action – September/October 2016

What is the NWHN doing to fight for women’s rights? Read on to find out.

Natural Doesn’t Always Mean Better!

By NWHN Staff | Jun 13, 2016 | Comments Off on Natural Doesn’t Always Mean Better!

This week the National Women’s Health Network was back at the FDA fighting for medically accurate information about the dangers of hormone therapy during menopause.

NWHN in Action – May/June 2016

By Sarah Christopherson | May 5, 2016 | Comments Off on NWHN in Action – May/June 2016

What is the NWHN doing to fight for women’s rights? Read on to find out.

Don’t Hate the Player, Hate the Game: Drug Pricing in America

By NWHN Staff | Mar 14, 2016 | Comments Off on Don’t Hate the Player, Hate the Game: Drug Pricing in America

Prescription drug price increases are incredibly common in the United States, with some drugs experiencing multiple price increases in a single year.

More Support for Osteoporosis Prevention – Not Osteoporosis Drugs

By NWHN Staff | Mar 1, 2016 | Comments Off on More Support for Osteoporosis Prevention – Not Osteoporosis Drugs

Bisphosphonate use for prevention has declined in recent years – and that’s a victory! But we’re concerned that a recent article in the Wall Street Journal with the misleading title “More Support for Osteoporosis Drugs: The benefits of bisphosphonates outweigh the risks for many patients” encourages the overuse of drugs that have not proven safe or effective as a preventive measure for women.

Rx for Change: Hepatitis Drugs and Skyrocketing Health Care Costs

By Charlea T. Massion, MD, and Adriane Fugh-Berman, MD | Jan 13, 2016 | Comments Off on Rx for Change: Hepatitis Drugs and Skyrocketing Health Care Costs

U.S. drug prices are out of control and unsustainable. We’re the only developed country where public programs cannot negotiate drug prices with pharmaceutical manufacturers; as a result, the U.S. generally pays more for branded prescription drugs than any other country.

NWHN in Action – January/February 2016

By NWHN Staff | Jan 13, 2016 | Comments Off on NWHN in Action – January/February 2016

What is the NWHN doing to fight for women’s rights? Read on to find out.

NWHN in Action – September/October 2015

By NWHN Staff | Sep 8, 2015 | Comments Off on NWHN in Action – September/October 2015

What is the NWHN doing to fight for women’s rights? Read on to find out.

Clinical Trials: Greater Inclusion of Women

By NWHN Staff | Aug 14, 2015 | Comments Off on Clinical Trials: Greater Inclusion of Women

The NWHN advocates for the greater participation of women and other key groups in clinical trials for all drugs and devices, and particularly for products that are principally marketed and used by women.

Rx for Change: Refuse InFuse

By Charlea T. Massion, MD, and Adriane Fugh-Berman, MD | Aug 4, 2015 | Comments Off on Rx for Change: Refuse InFuse

We all know that some pharmaceutical companies put their own corporate profits ahead of patient safety. But, those companies don’t have a lock on this behavior — here’s an example of a medical device company that has also compromised patient safety.